Toggle Nav
My Cart
Search
Menu
Account
Settings
Analysis of the Global Biosimilars Market

Impending Patent Expiries and Next-generation Biosimilars Pipeline Provide Impetus for Growth

INDUSTRY
Healthcare
SECTOR
Life Sciences

RELEASE DATE
16-Jan-2014
REGION
Global
DELIVERABLE TYPE
Market Research

RESEARCH CODE
M95E-01-00-00-00
SKU
LS00093-GL-MR_16934
Yes
SHARE

Analysis of the Global Biosimilars Market
Published on: 16-Jan-2014 | SKU: LS00093-GL-MR_16934

Need more details?

$10,000.00

$7,500.00 save 25 %

DownloadLink
Request Sample
Add to Compare
Need more details?
Description

Patent expirations of blockbuster biologics and a promising pipeline of biosimilars present positive opportunities for the global market. The research service provides analysis on regional market penetration and market dynamics. This study also provides a market overview, market engineering measurements, revenue forecasts, competitive analysis, and key trends for the biosimilars market and its segments. Regional analysis includes The United States, European countries such as the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia as well as Asia-Pacific and Latin America. The study period is 2009–2019, with 2012 as the base year.

Table of Contents

Introduction

  • Title, Research Team, Table of Contents, List of Exhibits, and Methodology

Executive Summary

  • Executive Summary and Key Findings

Market Overview

  • Overview

Competitive Playbook

  • Market Outlook

Drivers and Restraints for Total Market

  • Overview

Forecasts and Trends for Total Market

  • Overview

Competitive Analysis

  • Overview

Key Companies to Watch

  • Overview

Europe Breakdown

  • Overview

The United States Breakdown

  • Overview

China Breakdown

  • Overview

India Breakdown

  • Overview

South Korea Breakdown

  • Overview

Japan Breakdown

  • Overview

Australia Breakdown

  • Overview

Latin America Breakdown

  • Overview

Brazil Breakdown

  • Overview

Mexico Breakdown

  • Overview

Argentina Breakdown

  • Overview

The Last Word

  • Overview

Appendix

  • Additional Information
Request Sample

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Life Sciences research

13 Jan 2025   |   Global   |   Market Outlook

Top 6 Growth Opportunities for the Digital Health Industry, 2025

Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...

17 Dec 2024   |   Global   |   Market Research

Cybersecurity in Healthcare, United States, 2024

Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...

12 Dec 2024   |   Global   |   Market Outlook

Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025

Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...

05 Dec 2024   |   Global   |   Frost Radar

Frost Radar™: Enterprise Conversational AI in Healthcare, 2024

This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...

27 Nov 2024   |   Global   |   Market Research

Generative AI in Payer and Provider IT Transformation, Global, 2024-2029

The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

Prescription drug therapy for the treatment of obesity is experiencing a revival of interest with new government incentives and the recent approval of 2 new drugs, with 2 more pending imminent approval. This research service focuses on the competitive landscape of prescription drugs for the treatment of obesity. A global product and pipeline assessment is provided for marketed and investigational products. Segmentation by drug class is provided along with additional supporting information, such as clinical-trial timelines and results, historical and projected launch timelines, regulatory guidelines for clinical trial design and approval, and global epidemiology by region.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Author Srinivas Sashidhar
WIP Number M95E-01-00-00-00
Is Prebook No

Analysis of the Global Biosimilars Market

$10,000.00

Special Price $7,500.00 save 25 %

In stock
SKU
LS00093-GL-MR_16934